East Rutherford-based Cambrex Corp., a pharmaceutical manufacturer, announced Monday it has completed the construction of a new $3.2 million analytical laboratory at its High Point, North Carolina facility.
As a result of the new 11,000-square-foot laboratory investment, Cambrex said it plans to hire 12 new scientist.
“The addition of this new facility further expands our capabilities in method development and qualification and validation, to ensure successful project development in the short term, and allowing efficient technical transfer of projects to commercial scale in the future,” said Brian Swierenga, vice president, operations and site director for Cambrex High Point. “This expansion is part of Cambrex’s on-going strategic plan to increase development capacity and resources in North America.”
Cambex acquired the High Point site in October 2016. The expansion at the facility brings the investment at the site to over $5 million since Cambex acquired it.